Panel Discussion: Striking a Balance: Achieving Anticancer Activity without Toxicity
Time: 2:30 pm
day: Day Two
Details:
- Consider how we can investigate toxicity through dosimetry and how this data can be used in regulator submissions
- Discuss how dosimetry will play a role in taking on new cancer types
- How can we overcome the lack of clarity around the application and value of
dosimetry?
